Response to letter to the editor: ‘Gonadal tumour screening in XY gonadal dysgenesis’

Sabine E. Hannema; Katja P. Wolffenbuttel; Yolande van Bever; Hennie T. Bruggenwirth; Remko Hersmus; J. Wolter Oosterhuis; Leendert H.J. Looijenga

doi:10.1111/cen.15039

Response to letter to the editor: ‘Gonadal tumour screening in XY gonadal dysgenesis’

Sabine E. Hannema
, Katja P. Wolffenbuttel
, Yolande van Bever
, Hennie T. Bruggenwirth
, Remko Hersmus
, J. Wolter Oosterhuis
, Leendert H.J. Looijenga

Group Looijenga

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	466-467
Number of pages	2
Journal	Clinical endocrinology
Volume	100
Issue number	5
DOIs	https://doi.org/10.1111/cen.15039
Publication status	Published - May 2024

Access to Document

10.1111/cen.15039

Cite this

@article{6dd8aef5a8204cfeb74c093f698696b2,

title = "Response to letter to the editor: {\textquoteleft}Gonadal tumour screening in XY gonadal dysgenesis{\textquoteright}",

author = "Hannema, \{Sabine E.\} and Wolffenbuttel, \{Katja P.\} and \{van Bever\}, Yolande and Bruggenwirth, \{Hennie T.\} and Remko Hersmus and Oosterhuis, \{J. Wolter\} and Looijenga, \{Leendert H.J.\}",

year = "2024",

month = may,

doi = "10.1111/cen.15039",

language = "English",

volume = "100",

pages = "466--467",

journal = "Clinical endocrinology",

issn = "0300-0664",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Response to letter to the editor

T2 - ‘Gonadal tumour screening in XY gonadal dysgenesis’

AU - Hannema, Sabine E.

AU - Wolffenbuttel, Katja P.

AU - van Bever, Yolande

AU - Bruggenwirth, Hennie T.

AU - Hersmus, Remko

AU - Oosterhuis, J. Wolter

AU - Looijenga, Leendert H.J.

PY - 2024/5

Y1 - 2024/5

UR - https://www.scopus.com/pages/publications/85187477281

U2 - 10.1111/cen.15039

DO - 10.1111/cen.15039

M3 - Comment/debate

C2 - 38469934

AN - SCOPUS:85187477281

SN - 0300-0664

VL - 100

SP - 466

EP - 467

JO - Clinical endocrinology

JF - Clinical endocrinology

IS - 5

ER -